Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06554639
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-08-12
Brief Title:
A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants MK-5684-011
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Phase 1 Open-Label Fixed-Sequence Study to Evaluate the Effects of Multiple Doses of Diltiazem on the Single-Dose Pharmacokinetics of MK-5684 in Healthy Adult Male Participants
Status:
COMPLETED
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Researchers have designed a study medicine called MK-5684 as a new way to treat prostate cancer
The purpose of this study is to learn what happens to MK-5684 in a persons body over time a pharmacokinetic or PK study Researchers will compare what happens to MK-5684 in the body when it is given with and without another medicine called diltiazem
The purpose of this study is to learn what happens to MK-5684 in a persons body over time a pharmacokinetic or PK study Researchers will compare what happens to MK-5684 in the body when it is given with and without another medicine called diltiazem
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None